about
The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial HypertensionTreatment of patients with chronic thrombo embolic pulmonary hypertension: focus on riociguatQuality of life in patients with chronic thromboembolic pulmonary hypertensionBalloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary HypertensionAdaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval ProjectChronic thromboembolic pulmonary hypertension.Dyspnoea in a young woman: the opposite of every truth is just as true.Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressureChronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatmentChronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centersPulmonary Endarterectomy in a Patient with Immune Thrombocytopenic Purpura.Case report: Subjective loss of performance after pulmonary embolism in an athlete- beyond normal valuesThe Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension.Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomy.The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension.Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparisonNeutrophil/Lymphocyte Ratio Can Predict Postoperative Mortality in Patients with Chronic Thromboembolic Pulmonary Hypertension.An international physician survey of chronic thromboembolic pulmonary hypertension management.Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary AngioplastySurgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy.Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.Riociguat for the treatment of pulmonary hypertension.Proteomics of pulmonary hypertension: could personalized profiles lead to personalized medicine?Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options.Pulmonary hypertension in antiphospholipid syndrome.Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.Advanced imaging tools rather than hemodynamics should be the primary approach for diagnosing, following, and managing pulmonary arterial hypertension.Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches.
P2860
Q26744761-B6822DB1-182D-408D-B689-F71C7BDADEB8Q26746202-9835D811-E966-407C-8FB9-336C61956CC6Q26748611-A6C446B9-8A64-4E0F-8AE6-C669EE0294F6Q26776146-7D88612D-B598-4191-8F6C-7882B33D53C0Q27342609-1724449E-CDE9-4EF8-B580-5E893357A1C4Q28647204-16E63376-CDCF-47DC-8517-B36D4F374BCAQ30637782-7E50FF20-7C56-4B13-B321-7825776DE7CDQ33425705-86D5082F-6C62-4A0A-957C-471F9DCC75CCQ33693393-78495C02-B39C-4BAD-B95F-CE2AF6B85FE1Q33720450-54D447AF-45BC-4EC8-BB1D-03E9EC729EABQ33924397-9495C12F-715A-44F8-9746-5DAAACDB6D4FQ34436061-9237822A-B305-441C-A0DD-39DFAB087B73Q34444990-00BA52D9-9E87-431D-9A0B-17D730C883C6Q34549800-B95D2D68-2622-4F12-8BAF-12ACD4149618Q35214485-11E949F6-5428-419C-9D30-3EEF643D004EQ35354156-1C6B6D92-34E9-4D85-A8F9-C91C32EC3DF4Q35665777-BEE49EEB-611D-487E-A8F4-74AACBFDC2F6Q35680755-21B7079D-2802-4E22-9C0E-F874F028DEEBQ35907497-0C238AF5-C081-47A4-8BF8-A1169C424AB3Q35975165-136A86FE-ACF5-48AB-A5AC-D196611C0252Q36016478-CE759F07-401E-4586-BA08-88D129AC903FQ36067811-EAD9AE03-6D29-4F6B-BC73-19F7AF2A719CQ36115857-ED90A58C-2F68-4362-BC0C-9953C7821E38Q36345655-3A7F6788-A855-4149-9BF6-F447D72B5EDBQ36908834-8F0A2EB3-4DA1-4639-A855-2FE7AE1E48A5Q36928024-C1BFB2F8-8E87-45C0-91FE-1160CAD19AC9Q36982785-A65B3C75-3486-4A70-8B4D-1E6DA58178DAQ37186830-EF09606A-1D4F-4214-9167-305C208D1BFEQ37555381-EC14C252-8C59-4090-9106-61277550A90AQ37691671-DA1DECB4-AD62-4371-BA2C-E43D8101F8E5Q37691674-B833A0CC-70FD-42E3-ACB2-DED6B281B75BQ38225794-72A51436-6C30-4F4A-BA2E-466779793440Q38254736-2557EE27-C869-49A9-93C2-0A8A421243B8Q38269463-08FAA3DA-25BA-4740-BF63-1E8D178B489BQ38283873-785F5CE8-DDD4-4C54-86F2-2162DFB5870BQ38325716-AAADA78D-4987-457C-BD4B-5D7A1617B974Q38379154-AAC47841-2FB0-485B-8DEE-577946C46204Q38386942-959326A7-7F8E-4205-A180-90DC4DA8ADBEQ38404334-1D0C6A49-B66C-4077-8FFD-226DB43D57F0Q38479613-ED9C2436-B622-4020-8ED1-274F2645CA92
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chronic thromboembolic pulmonary hypertension
@ast
Chronic thromboembolic pulmonary hypertension
@en
Chronic thromboembolic pulmonary hypertension
@nl
type
label
Chronic thromboembolic pulmonary hypertension
@ast
Chronic thromboembolic pulmonary hypertension
@en
Chronic thromboembolic pulmonary hypertension
@nl
prefLabel
Chronic thromboembolic pulmonary hypertension
@ast
Chronic thromboembolic pulmonary hypertension
@en
Chronic thromboembolic pulmonary hypertension
@nl
P2093
P921
P3181
P1476
Chronic thromboembolic pulmonary hypertension
@en
P2093
David P Jenkins
Eckhard Mayer
Hitoshi Ogino
Irene Lang
Marion Delcroix
Michael M Madani
Nick H Kim
Philippe Dartevelle
Richard Channick
P3181
P356
10.1016/J.JACC.2013.10.024
P407
P433
P577
2013-12-24T00:00:00Z